サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1532825

細胞・遺伝子治療製造サービス市場：治療タイプ別、細胞タイプ別、サービスタイプ別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測

Cell and Gene Therapy Manufacturing Services Market, By Therapy Type, By Cell Type, By Service Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 399 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
細胞・遺伝子治療製造サービス市場：治療タイプ別、細胞タイプ別、サービスタイプ別、エンドユーザー別、国別、地域別-産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年07月30日
発行: AnalystView Market Insights
ページ情報: 英文 399 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

細胞・遺伝子治療製造サービス市場規模は2023年に59億7,700万米ドルとなり、2024～2032年にかけてCAGR 17.2%で拡大

細胞・遺伝子治療製造サービス市場-市場力学

遺伝子疾患とがんの有病率の増加が細胞・遺伝子治療製造サービスの必要性を高める

遺伝性疾患やがんの有病率の増加は、細胞・遺伝子治療製造サービスの需要を大きく促進しています。例えば、米国国立がん研究所（National Cancer Institute）の報告によると、2024年には米国だけで190万人近いがん患者が新たに発生すると予想されており、高度な治療ソリューションの緊急ニーズが浮き彫りになっています。同様に、世界保健機関（WHO）は、遺伝性疾患は世界人口の約20人に1人が罹患しており、専門的な治療法の必要性を高めていると指摘しています。このセグメントへの最近の投資は注目に値するもので、米国立衛生研究所は昨年、遺伝子治療研究に10億米ドル以上の助成金を割り当てた。さらに、NovartisやBluebird Bioのような大手企業は、これらの最先端治療に対する需要の高まりに対応するために製造能力を拡大しており、これは革新的な治療を通じて患者の転帰を改善することへの関心の高まりを反映しています。

細胞・遺伝子治療製造サービス市場-主要洞察

当社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約17.2%のCAGRで毎年成長すると予測されています。

治療タイプ別では、遺伝子治療が2023年に最大の市場シェアを示すと予測されています。

細胞タイプ別では、2023年には自己細胞が主要タイプとなっています。

サービスタイプ別では、CDMO（Contract Development and Manufacturing Organization）が2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップ

細胞・遺伝子治療製造サービス市場-セグメンテーション分析：

細胞・遺伝子治療製造サービスの世界市場は、治療タイプ、細胞タイプ、サービスタイプ、エンドユーザー、地域に基づいて区分されます。

市場は治療タイプによって2つのカテゴリーに分けられます：細胞療法と遺伝子療法です。細胞療法は治療用細胞の生産と操作に重点を置き、遺伝子療法は遺伝物質を変化させて疾病に対処する治療法の開発に関与します。

市場は細胞タイプによって2つのカテゴリーに分けられます：自己細胞」と「同種細胞」です。一方、同種細胞はドナーから供給され、より幅広い応用の可能性があります。

細胞・遺伝子治療製造サービス市場-地理的洞察

北米、特に米国は、高度な研究インフラ、多額の資金、専門製造施設の強固なネットワークにより市場をリードしています。欧州では、ドイツや英国などの国も重要な参入企業であり、強力な規制の枠組みや、バイオテクノロジー企業と研究機関の協力関係の増加などの恩恵を受けています。一方、アジア太平洋は急速に台頭しており、中国や日本などの国々がバイオテクノロジーの革新に多額の投資を行い、製造能力を拡大しています。例えば、中国が最近遺伝子治療インフラに5億米ドルを投資したことは、このセグメントで主要な参入企業になることに注力しつつあることを反映しています。

細胞・遺伝子治療製造サービス市場-競合情勢：

Lonza、Catalent、WuXi AppTecなどの主要企業は、広範な製造能力と世界の展開力で市場を独占しており、細胞加工から遺伝子編集まで幅広いサービスを提供しています。これらの企業は、最先端技術への多額の投資と戦略的パートナーシップによって強化されています。例えば、CAR-T細胞療法の製造能力を強化するためのLonzaとNovartisとの提携は、業界提携の深化という動向を浮き彫りにしています。新興のバイオテクノロジー企業や製造受託機関（CMO）も、専門的なサービスを提供し、イノベーションを推進する上で重要な役割を果たしています。競合環境は、技術の絶え間ない進歩、規制の適応、スケーラブルで効率的な製造ソリューションの重視によって特徴付けられています。

目次

第1章 細胞・遺伝子治療製造サービス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 細胞・遺伝子治療製造サービスの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 細胞・遺伝子治療製造サービス産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 細胞・遺伝子治療製造サービス市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 細胞・遺伝子治療製造サービス市場情勢

  • 細胞・遺伝子治療製造サービス市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 細胞・遺伝子治療製造サービス市場-治療タイプ別

  • 概要
    • 治療タイプ別セグメントシェア分析
    • 細胞療法
    • 遺伝子治療

第8章 細胞・遺伝子治療製造サービス市場-細胞タイプ別

  • 概要
    • 細胞タイプ別セグメントシェア分析
    • 自己細胞
    • 同種細胞

第9章 細胞・遺伝子治療製造サービス市場-サービスタイプ別

  • 概要
    • サービスタイプ別セグメントシェア分析
    • 受託開発製造組織（CDMO）
    • 研究機関（CRO）
    • 製造技術ソリューション

第10章 細胞・遺伝子治療製造サービス市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 製薬会社
    • バイオテクノロジー企業
    • 学術機関
    • 研究機関

第11章 細胞・遺伝子治療製造サービス市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析-細胞・遺伝子治療製造サービス業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Adaptimmune Therapeutics plc
    • Bluebird Bio, Inc.
    • Catalent, Inc.
    • Celyad Oncology SA
    • Charles River Laboratories International, Inc.
    • Gene Therapy Research Group
    • Kiadis Pharma NV
    • Lonza Group AG
    • MaxCyte, Inc.
    • Miltenyi Biotec GmbH
    • Orchard Therapeutics plc
    • Rocket Pharmaceuticals, Inc.
    • Sangamo Therapeutics, Inc.
    • Sarepta Therapeutics, Inc.
    • TCR2 Therapeutics Inc.
    • WuXi AppTec
    • その他

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Therapy Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Therapy Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Cell Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Cell Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Service Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Service Type
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Service Type 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by End-User 2019-2032 (USD Million)
  • TABLE Cell and Gene Therapy Manufacturing Services Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Cell and Gene Therapy Manufacturing Services Market, by Region 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE North America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Europe Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Latin America Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Therapy Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by Service Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Cell and Gene Therapy Manufacturing Services Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Therapy Type segment market share analysis, 2023 & 2032
  • FIGURE Therapy Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Cell Type segment market share analysis, 2023 & 2032
  • FIGURE Cell Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Service Type segment market share analysis, 2023 & 2032
  • FIGURE Service Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Germany Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE India Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Brazil Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Cell and Gene Therapy Manufacturing Services Market share analysis by country, 2023
  • FIGURE Saudi Arabia Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Cell and Gene Therapy Manufacturing Services Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3413

REPORT HIGHLIGHT

Cell and Gene Therapy Manufacturing Services Market size was valued at USD 5,977 Million in 2023, expanding at a CAGR of 17.2% from 2024 to 2032.

The Cell and Gene Therapy Manufacturing Services Market encompasses specialized services for the production of cell and gene therapies, which are revolutionary treatments targeting genetic disorders and various diseases. The rising prevalence of genetic disorders and cancer, coupled with advancements in personalized medicine, is fueling the market's expansion. However, challenges such as high production costs and complex regulatory requirements act as significant restraints. Opportunities are emerging in the form of increased investments in research and development, with global funding for cell and gene therapies having surged by approximately 30% in the past year. Additionally, partnerships between biotech firms and contract manufacturing organizations (CMOs) are on the rise, aiming to streamline production processes and enhance scalability.

Cell and Gene Therapy Manufacturing Services Market- Market Dynamics

Growing Prevalence of Genetic Disorders and Cancer Fuels Need for Cell and Gene Therapy Manufacturing Services

The increasing prevalence of genetic disorders and cancer is significantly driving the demand for Cell and Gene Therapy Manufacturing Services. For instance, the National Cancer Institute reports that nearly 1.9 million new cancer cases were expected in the U.S. alone in 2024, underscoring the urgent need for advanced therapeutic solutions. Similarly, the World Health Organization notes that genetic disorders affect about 1 in 20 people globally, amplifying the need for specialized therapies. Recent investments in this field have been notable, with the National Institutes of Health allocating over $1 billion in grants for gene therapy research in the past year. Additionally, leading companies like Novartis and Bluebird Bio have expanded their manufacturing capabilities to meet the rising demand for these cutting-edge treatments, reflecting a growing focus on improving patient outcomes through innovative therapies.

Cell and Gene Therapy Manufacturing Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 17.2% over the forecast period (2024-2032)

Based on Therapy Type segmentation, Gene Therapy was predicted to show maximum market share in the year 2023

Based on Cell Type segmentation, Autologous Cells was the leading type in 2023

Based on Service Type segmentation, Contract Development and Manufacturing Organization (CDMO) was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cell and Gene Therapy Manufacturing Services Market- Segmentation Analysis:

The Global Cell and Gene Therapy Manufacturing Services Market is segmented based on Therapy Type, Cell Type, Service Type, End-User, and Region.

The market is divided into two categories based on Therapy Type: Cell Therapy and Gene Therapy. Cell Therapy focuses on the production and manipulation of cells for therapeutic use, while Gene Therapy involves the development of treatments that alter genetic material to address diseases.

The market is divided into two categories based on Cell Type: Autologous Cells and Allogeneic Cells. Autologous Cells are derived from the patient's own body, ensuring compatibility, while Allogeneic Cells are sourced from donors and offer broader application potential.

Cell and Gene Therapy Manufacturing Services Market- Geographical Insights

North America, particularly the United States, leads the market due to its advanced research infrastructure, substantial funding, and a robust network of specialized manufacturing facilities. In Europe, countries such as Germany and the United Kingdom are also significant players, benefiting from strong regulatory frameworks and increasing collaboration between biotech companies and research institutions. Meanwhile, the Asia-Pacific region is emerging rapidly, with countries like China and Japan investing heavily in biotech innovations and expanding their manufacturing capabilities. For example, China's recent $500 million investment in gene therapy infrastructure reflects its growing focus on becoming a major player in this sector.

Cell and Gene Therapy Manufacturing Services Market- Competitive Landscape:

Key players such as Lonza, Catalent, and WuXi AppTec dominate the market with extensive manufacturing capabilities and global reach, providing a range of services from cell processing to gene editing. These companies are bolstered by significant investments in cutting-edge technologies and strategic partnerships. For instance, Lonza's collaboration with Novartis to enhance manufacturing capacity for CAR-T cell therapies highlights the trend towards deepening industry alliances. Emerging biotech firms and contract manufacturing organizations (CMOs) also play a crucial role, offering specialized services and driving innovation. The competitive environment is characterized by continuous advancements in technology, regulatory adaptations, and an emphasis on scalable and efficient manufacturing solutions.

Recent Developments:

In May 2024, ProPharma, in collaboration with PBL, introduced the Cell Factory Box (CF Box), a fully automated and enclosed cell factory device designed for the production of cell and gene therapies (CGTs). The CF Box facilitates decentralized manufacturing of various CGTs within Class D (ISO8) or controlled, non-classified environments.

In May 2024, Bristol Myers Squibb signed a USD 380 million deal with Cellares to produce CAR T-cell therapies, highlighting the rising demand for outsourced cell and gene therapy manufacturing services. Cellares plans to expand its automated manufacturing units in the US, Europe, and Japan.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Adaptimmune Therapeutics plc

Bluebird Bio, Inc.

Catalent, Inc.

Celyad Oncology SA

Charles River Laboratories International, Inc.

Gene Therapy Research Group

Kiadis Pharma N.V.

Lonza Group AG

MaxCyte, Inc.

Miltenyi Biotec GmbH

Orchard Therapeutics plc

Rocket Pharmaceuticals, Inc.

Sangamo Therapeutics, Inc.

Sarepta Therapeutics, Inc.

TCR2 Therapeutics Inc.

WuXi AppTec

Others

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY THERAPY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cell Therapy
  • Gene Therapy

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Cells
  • Allogeneic Cells

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Contract Development and Manufacturing Organization (CDMO)
  • Contract Research Organization (CRO)
  • Manufacturing Technology Solutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutions
  • Research Institutions

GLOBAL CELL AND GENE THERAPY MANUFACTURING SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cell and Gene Therapy Manufacturing Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cell and Gene Therapy Manufacturing Services Market Snippet by Therapy Type
    • 2.1.2. Cell and Gene Therapy Manufacturing Services Market Snippet by Cell Type
    • 2.1.3. Cell and Gene Therapy Manufacturing Services Market Snippet by Service Type
    • 2.1.4. Cell and Gene Therapy Manufacturing Services Market Snippet by End-User
    • 2.1.5. Cell and Gene Therapy Manufacturing Services Market Snippet by Country
    • 2.1.6. Cell and Gene Therapy Manufacturing Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Cell and Gene Therapy Manufacturing Services Key Market Trends

  • 3.1. Cell and Gene Therapy Manufacturing Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cell and Gene Therapy Manufacturing Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cell and Gene Therapy Manufacturing Services Market Opportunities
  • 3.4. Cell and Gene Therapy Manufacturing Services Market Future Trends

4. Cell and Gene Therapy Manufacturing Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cell and Gene Therapy Manufacturing Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cell and Gene Therapy Manufacturing Services Market Landscape

  • 6.1. Cell and Gene Therapy Manufacturing Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cell and Gene Therapy Manufacturing Services Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2023 & 2032 (%)
    • 7.1.2. Cell Therapy
    • 7.1.3. Gene Therapy

8. Cell and Gene Therapy Manufacturing Services Market - By Cell Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
    • 8.1.2. Autologous Cells
    • 8.1.3. Allogeneic Cells

9. Cell and Gene Therapy Manufacturing Services Market - By Service Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
    • 9.1.2. Contract Development and Manufacturing Organization (CDMO)
    • 9.1.3. Contract Research Organization (CRO)
    • 9.1.4. Manufacturing Technology Solutions

10. Cell and Gene Therapy Manufacturing Services Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Pharmaceutical Companies
    • 10.1.3. Biotechnology Companies
    • 10.1.4. Academic Institutions
    • 10.1.5. Research Institutions

11. Cell and Gene Therapy Manufacturing Services Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Cell and Gene Therapy Manufacturing Services Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cell and Gene Therapy Manufacturing Services Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Adaptimmune Therapeutics plc
    • 12.2.2. Bluebird Bio, Inc.
    • 12.2.3. Catalent, Inc.
    • 12.2.4. Celyad Oncology SA
    • 12.2.5. Charles River Laboratories International, Inc.
    • 12.2.6. Gene Therapy Research Group
    • 12.2.7. Kiadis Pharma N.V.
    • 12.2.8. Lonza Group AG
    • 12.2.9. MaxCyte, Inc.
    • 12.2.10. Miltenyi Biotec GmbH
    • 12.2.11. Orchard Therapeutics plc
    • 12.2.12. Rocket Pharmaceuticals, Inc.
    • 12.2.13. Sangamo Therapeutics, Inc.
    • 12.2.14. Sarepta Therapeutics, Inc.
    • 12.2.15. TCR2 Therapeutics Inc.
    • 12.2.16. WuXi AppTec
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us